AF9 Antikörper (C-Term)
-
- Target Alle AF9 (MLLT3) Antikörper anzeigen
- AF9 (MLLT3) (Protein AF-9 (MLLT3))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human, Maus, Ratte, Hund, Zebrafisch (Danio rerio), Xenopus laevis
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser AF9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Kreuzreaktivität
- Maus, Ratte (Rattus), Hund, Zebrafisch (Brachydanio rerio), Frosch
- Aufreinigung
- Purified
- Immunogen
- MLLT3 antibody was raised in rabbit using the C terminal of MLLT3 as the immunogen
- Top Product
- Discover our top product MLLT3 Primärantikörper
-
anti-Protein AF-9 (MLLT3) (AA 471-502), (C-Term) antibody
MLLT3 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB2249-2250 unconjugated
anti-Protein AF-9 (MLLT3) (Center) antibodyMLLT3 Reaktivität: Human WB, IHC (p), IF, ChIP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Protein AF-9 (MLLT3) (C-Term) antibodyMLLT3 Reaktivität: Human WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Protein AF-9 (MLLT3) (C-Term) antibodyMLLT3 Reaktivität: Human, Maus, Rind (Kuh), Ratte, Hund, Kaninchen, Pferd, Zebrafisch (Danio rerio), Meerschweinchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-Protein AF-9 (MLLT3) (C-Term) antibodyMLLT3 Reaktivität: Human WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Protein AF-9 (MLLT3) (AA 1-150) antibodyMLLT3 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Protein AF-9 (MLLT3) (AA 407-438) antibodyMLLT3 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB6799 unconjugated
anti-Protein AF-9 (MLLT3) (AA 1-568) antibodyMLLT3 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3C11 unconjugated
anti-Protein AF-9 (MLLT3) (N-Term) antibodyMLLT3 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Protein AF-9 (MLLT3) (N-Term) antibodyMLLT3 Reaktivität: Human, Maus, Rind (Kuh), Ratte, Hund, Kaninchen, Pferd, Zebrafisch (Danio rerio), Meerschweinchen WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
MLLT3 Blocking Peptide, catalog no. 33R-2694, is also available for use as a blocking control in assays to test for specificity of this MLLT3 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- AF9 (MLLT3) (Protein AF-9 (MLLT3))
- Andere Bezeichnung
- MLLT3 (MLLT3 Produkte)
- Synonyme
- fc39c11 antikoerper, wu:fc39c11 antikoerper, zgc:110210 antikoerper, AF9 antikoerper, YEATS3 antikoerper, 2210011H10Rik antikoerper, 2610012I03Rik antikoerper, 3830408D16Rik antikoerper, Af9 antikoerper, D4Ertd321e antikoerper, Af-9 antikoerper, MLLT3, super elongation complex subunit antikoerper, myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 antikoerper, mllt3 antikoerper, MLLT3 antikoerper, Mllt3 antikoerper
- Hintergrund
- MLLT3 is a regulator of early erythroid and megakaryocytic cell fate in the human system. Expression of MLLT3 in human CD34+ cells induces acute myeloid, lymphoid, or mixed-lineage leukemia in immunodeficient mice. Synonyms: Polyclonal MLLT3 antibody, Anti-MLLT3 antibody, myeloid/lymphoid or mixed-lineage leukemia, trithorax homolog, Drosophila, translocated to, 3 antibody, AF9 antibody, FLJ2035 antibody, YEATS3 antibody.
-
